FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.

Authors:
Zhou Z; Zhang B; Deng Y; Deng S; Li J and 15 more

Journal:
J Exp Clin Cancer Res

Publication Year: 2024

DOI:
10.1186/s13046-024-02959-3

PMCID:
PMC10823633

PMID:
38281999

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Exp Clin Cancer Res

Abbreviation: J Exp Clin Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitax…
Bergonzini C; Gregori A; Hagens TMS and 13 more (2024) - Transparency Score: 4/6
A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration …
Bartolomé RA; Pintado-Berninches L; Martín-Regalado Á and 7 more (2024) - Transparency Score: 3/6
A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates t…
Feng C; Yu A; Wang Z and 9 more (2024) - Transparency Score: 3/6
A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis …
Zhang Y; Liu Z; Zhong Z and 4 more (2024) - Transparency Score: 3/6
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram com…
Meraz-Torres F; Niessner H; Plöger S and 12 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by the Animal Use and Care Committees at Tongji Medical College, Huazhong University of Science and Technology. Consent for publicationNot applicable. Competing interestsThe authors have declared no competing interests. Competing interests The authors have declared no competing interests."

Evidence found in paper:

"Funding This work was financially supported by the National Natural Science Foundation of China (82073354 to KY, 82002896 to YL, 82102843 to YS, 82102201 to CW)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025